Inventor · disambiguated record
Anil K. Saksena
Also filed as: SAKSENA ANIL · SAKSENA ANIL K
61 granted patents·5 pending applications·1,619 citations·filing 1976–2011
99Inventor score
Top patents by PatentIndex Score
66 records- 0197US7012066B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Mar 14, 2006·176 cites·64 claims
- 0296US7186747B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2005·Granted Mar 6, 2007·47 cites·31 claims
- 0396US6800434B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2001·Granted Oct 5, 2004·89 cites·1 claims
- 0496US4076711ATriazolo [4,5-d]-pyrimidinesSCHERING CORP·Filed 1976·Granted Feb 28, 1978·55 cites·6 claims
- 0595US7425576B2Compounds as inhibitors of hepatitis C virus NS3 serine proteaseSCHERING CORP·Filed 2006·Granted Sep 16, 2008·20 cites·24 claims
- 0695US7205330B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2005·Granted Apr 17, 2007·54 cites·29 claims
- 0795US7169760B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2001·Granted Jan 30, 2007·88 cites·30 claims
- 0895US6846802B2Macrocyclic NS3-serine protease inhibitors of hepatitis C virus comprising N-cyclic P2 moietiesSCHERING CORP·Filed 2001·Granted Jan 25, 2005·124 cites·21 claims
- 0995US6239140B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1998·Granted May 29, 2001·64 cites·4 claims
- 1094US7423058B2Inhibitors of hepatitis C virus NS3 proteaseSCHERING CORP·Filed 2006·Granted Sep 9, 2008·15 cites·22 claims
- 1194US7244721B2Peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2002·Granted Jul 17, 2007·80 cites·67 claims
- 1294US5661151ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Aug 26, 1997·69 cites·13 claims
- 1393US6403564B1Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 1999·Granted Jun 11, 2002·122 cites·2 claims
- 1493US6277830B15′-amino acid esters of ribavirin and the use of same to treat hepatitis C with interferonSCHERING CORP·Filed 1999·Granted Aug 21, 2001·120 cites·43 claims
- 1592US6894072B2Compounds as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2003·Granted May 17, 2005·59 cites·25 claims
- 1692US5039676ATri- and tetra-substituted-oxetanes and tetrahydrofurans and intermediates thereofSCHERING CORP·Filed 1990·Granted Aug 13, 1991·54 cites·12 claims
- 1791US6225322B1Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 1998·Granted May 1, 2001·59 cites·20 claims
- 1889USRE43298EPeptides as NS3-serine protease inhibitors of hepatitis C virusSAKSENA ANIL K·Filed 2011·Granted Apr 3, 2012·17 cites·66 claims
- 1987US5714490ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Feb 3, 1998·37 cites·20 claims
- 2086US4517200AMethod for treating allergic reactions with forskolinSCHERING PLOUGH CORP·Filed 1983·Granted May 14, 1985·30 cites·10 claims
- 2183US8067379B2Sulfur compounds as inhibitors of hepatitis C virus NS3 serine proteaseBENNETT FRANK·Filed 2005·Granted Nov 29, 2011·8 cites·43 claims
- 2280US7138396B217 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2005·Granted Nov 21, 2006·3 cites·12 claims
- 2380US5693626ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 2, 1997·24 cites·11 claims
- 2479US6924270B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Aug 2, 2005·11 cites·16 claims
- 2579US5403937AProcess for preparing intermediates for the synthesis of antifungal agentsSCHERING CORP·Filed 1993·Granted Apr 4, 1995·21 cites·16 claims
- 2677US7115578B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2004·Granted Oct 3, 2006·8 cites·7 claims
- 2776US6689789B2Compounds useful for inhibition of farnesyl protein transferaseSCHERING CORP·Filed 2002·Granted Feb 10, 2004·5 cites·14 claims
- 2876US4999428AProcess for preparing cyclopentyl purine derivativesSCHERING CORP·Filed 1989·Granted Mar 12, 1991·12 cites·14 claims
- 2974US7485645B217β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2007·Granted Feb 3, 2009·1 cites·2 claims
- 3074US7432268B217β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2005·Granted Oct 7, 2008·1 cites·16 claims
- 3174US7271175B217β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2006·Granted Sep 18, 2007·1 cites·9 claims
- 3274US6673775B2Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infectionSCHERING CORP·Filed 2001·Granted Jan 6, 2004·4 cites·38 claims
- 3374US5703079ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·16 cites·9 claims
- 3471US5925648ATricyclic N-cyanoimines useful as inhibitors of a farnesyl-protein transferaseSCHERING CORP·Filed 1997·Granted Jul 20, 1999·16 cites·13 claims
- 3570US5710154ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Jan 20, 1998·13 cites·20 claims
- 3669US6903102B217β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2002·Granted Jun 7, 2005·3 cites·29 claims
- 3766US5015739AProcesses for preparation of cyclopentyl purine derivativesSCHERING CORP·Filed 1988·Granted May 14, 1991·7 cites·13 claims
- 3865US5883097ASoluble azole antifungal saltSCHERING CORP·Filed 1998·Granted Mar 16, 1999·9 cites·18 claims
- 3965US4782082AMethod for treating allergic reactions with ForskolinSCHERING CORP·Filed 1986·Granted Nov 1, 1988·7 cites·9 claims
- 4059US5346898AAnti-fungal uracil compoundsSCHERING CORP·Filed 1992·Granted Sep 13, 1994·8 cites·8 claims
- 4157US2006205672A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2005·Application pending·0 cites
- 4256US7053091B217 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseasesSCHERING CORP·Filed 2003·Granted May 30, 2006·0 cites·22 claims
- 4355US5238926AAnti-fungal agentsSCHERING CORP·Filed 1992·Granted Aug 24, 1993·8 cites·8 claims
- 4454US5703236ATetrahydrofuran antifungalsSCHERING CORP·Filed 1995·Granted Dec 30, 1997·11 cites·4 claims
- 4554US5618793ANikkomycin analogsSCHERING CORP·Filed 1995·Granted Apr 8, 1997·6 cites·8 claims
- 4653US2011117057A1Novel peptides as ns3-serine protease inhibitors of hepatitis c virusSCHERING CORP·Filed 2010·Application pending·0 cites
- 4753US2005059606A1Novel peptides as NS3-serine protease inhibitors of hepatitis C virusDENDREON CORP·Filed 2004·Application pending·0 cites
- 4851US7595299B2Peptides as NS3-serine protease inhibitors of hepatitis C virusSCHERING CORP·Filed 2005·Granted Sep 29, 2009·0 cites·5 claims
- 4950US4696946ATopical Treatment of hyperproliferative skin diseasesSCHERING CORP·Filed 1985·Granted Sep 29, 1987·15 cites·13 claims
- 5050US2004157872A1Compounds useful for inhibition of farnesyl protein transferaseFiled 2004·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Anil K. Saksena files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →